Before the Court in MOLECULAR PATHOLOGY V. MYRIAD GENETICS
The Justices Weigh in on Patenting Human DNA
A t 10:14 a.m. on April 15, 2013, the U.S. Supreme Court heard oral arguments for case number 12–398, Association for Molecular Pathology, et al. v. Myriad Genetics, Inc., et al. At 11:11 a.m., arguments concluded and the case was submitted for judgment. Following are excerpts from the arguments of Christopher Hansen, counsel for the Association for Molecular Pathology, et al., and Gregory Castanias, counsel for Myriad Genetics, et al. Questions are presented from the nine Supreme Court Justices. Argument on Behalf of Association for Molecular Pathology, et al. MR. HANSEN: One way to address the question presented by this…
